Early Amiodarone-Induced Pulmonary Toxicity after Endovascular Aneurysm Repair: A Case Report

Abstract

Amiodarone is an antiarrhythmic drug that has been commonly used to treat supraventricular and ventricular arrhythmias. This drug is an iodine-containing compound that tends to accumulate in several organs, including the lungs. Especially, its main metabolically active metabolite desethylamiodarone can adversely affect many organs. A very well-known severe complication of amiodarone therapy is the amiodarone-induced pulmonary toxicity. This article presents the case study of an 82-year-old male patient with acute amiodarone-induced pulmonary toxicity. The patient underwent endovascular aneurysm repair for rapidly increasing abdominal aortic aneurysm. During the postoperative period the patient developed rapid atrial fibrillation and amiodarone therapy was initiated. Subsequently, the patient went into acute respiratory failure and was requiring high supplemental oxygen support and a chest X-ray revealed bilateral pulmonary infiltrates. During the hospital course the patient required mechanical ventilator support. With discontinuation of amiodarone, supportive therapy and steroid treatment patient symptoms significantly improved. Amiodarone-induced pulmonary toxicity must be considered in the differential diagnosis of all patients on the medication with progressive or acute respiratory symptoms. Early discontinuation of amiodarone and aggressive corticosteroid therapy should be considered as a viable treatment strategy.

Keywords

endovascular - aneurysm - amiodarone - pulmonary toxicity

• Reference

• 1 Viswam D, Nair SG, Patel V , Nagaraj Ultra-short course of low-dose amiodarone-induced post-operative fatal pulmonary toxicity. J Assoc Physicians India 2011; 59: 443-447
• 2 Lee W, Ryu DR, Han SS , et al. Very early onset of amiodarone-induced pulmonary toxicity. Korean Circ J 2013; 43 (10) 699-701
• 3 Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007; 298 (11) 1312-1322
• 4 Plomp TA, Wiersinga WM, Van Rossum JM, Maes RA. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration. In Vivo 1987; 1 (5) 265-279
• 5 Goldschlager N, Epstein AE, Naccarelli GV , et al; Practice Guidelines Sub-committee, North American Society of Pacing and Electrophysiology (HRS). A practical guide for clinicians who treat patients with amiodarone: 2007. Heart Rhythm 2007; 4 (9) 1250-1259
• 6 Mankikian J, Favelle O, Guillon A , et al. Initial characteristics and outcome of hospitalized patients with amiodarone pulmonary toxicity. Respir Med 2014; 108 (4) 638-646
• 7 Papiris SA, Triantafillidou C, Kolilekas L, Markoulaki D, Manali ED. Amiodarone: review of pulmonary effects and toxicity. Drug Saf 2010; 33 (7) 539-558
• 8 Ernawati DK, Stafford L, Hughes JD. Amiodarone-induced pulmonary toxicity. Br J Clin Pharmacol 2008; 66 (1) 82-87
• 9 Jessurun GA, Crijns HJG. Amiodarone pulmonary toxicity. BMJ 1997; 314 (7081) 619-620
• 10 Camus P, Martin II WJ, Rosenow III EC. Amiodarone pulmonary toxicity. Clin Chest Med 2004; 25 (1) 65-75
• 11 Wolkove N, Baltzan M. Amiodarone pulmonary toxicity. Can Respir J 2009; 16 (2) 43-48
• 12 Ashrafian H, Davey P. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU?. Chest 2001; 120 (1) 275-282
• 13 Saussine M, Colson P, Alauzen M, Mary H. Postoperative acute respiratory distress syndrome. A complication of amiodarone associated with 100 percent oxygen ventilation. Chest 1992; 102 (3) 980-981
• 14 Rosenow III EC. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I). Chest 1988; 93: 1067-1075
• 15 Martin II WJ, Rosenow III EC. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2). Chest 1988; 93 (6) 1242-1248
• 16 Yamada Y, Shiga T, Matsuda N, Hagiwara N, Kasanuki H. Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone. Circ J 2007; 71 (10) 1610-1616
• 17 Dharmarajan TS, Shah AB, Dharmarajan L. Amiodarone-induced pulmonary toxicity: potentially fatal, recognize early during life!. J Am Geriatr Soc 2008; 56 (7) 1363-1365
• 18 Morera J, Vidal R, Morell F, Ruiz J, Bernadó LL, Laporte JR. Pulmonary fibrosis and amiodarone. Br Med J (Clin Res Ed) 1982; 285 (6345) 895
• 19 Gleadhill IC, Wise RA, Schonfeld SA , et al. Serial lung function testing in patients treated with amiodarone: a prospective study. Am J Med 1989; 86 (1) 4-10
• 20 Nacca N, Bhamidipati CM, Yuhico LS, Pinnamaneni S, Szombathy T. Severe amiodarone induced pulmonary toxicity. J Thorac Dis 2012; 4 (6) 667-670